LC and UV Methods for Lamotrigine Determination in Pharmaceutical Formulation
Figure 2
Mobile phase without the additive triethylamine (0.3%) (a) and the use and influence in peak shapes with the additive triethylamine (0.3%) in the mobile phase (b).